Corporate
Hims Launches $49 Compounded Wegovy Pill, Novo Nordisk Stock Drops 7%
Yesterday
You're signed outSign in or to get full access.
H&
Hims & Hers Health (HIMS)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering Hims & Hers Health.